Top Railroad Companies To Watch For 2015

Top Railroad Companies To Watch For 2015: Total SA (FP)

Total SA is a France-based integrated international oil and gas company. It is an integrated international oil and gas company and a chemicals manufacturer. Total engages in all aspects of the petroleum industry, including Upstream operations (oil exploration and production, together with activities related to natural gas), Refining & Chemicals (refining, petrochemicals, speciality chemicals, crude oil trading and shipping) and Marketing & Services (focused on the supply and sale of petroleum products, together with activities related to renewable energy). In April 12, 2013, it inaugurated the partnership with Veolia Environnement SA the Osilub plant. In July 2013, it sold its TIGF (Transport et Infrastructures Gaz France), gas transport and storage business. In September 2013, it announced the transfer to The National Gas Company of Trinidad &Tobago of all of its E&P assets in Trinidad through the sale of Total E&P Trinidad B.V and Elf Exploration Trinidad B.V. Advisors' Opinion:

• [By Namitha Jagadeesh]

  Telecom Italia (TIT) SpA gained 1.7 percent as Telefonica SA agreed to increase its stake in the phone operator. Nokia Oyj added 2.4 percent after a U.S. judge found that HTC Corp. violated two of its patents. Total (FP) SA climbed 2.6 percent after Barclays Plc raised its rating on the oil producer. Burckhardt Compression Holding AG slid 7.3 percent after saying fiscal first-half net income will decline from the year-earlier period.

• [By Sofia Horta e Costa]

  Lloyds dropped 3.5 percent after the U.K. government sold a 3.2 billion-pound ($5.1 billion) stake in the lender. Continental and Galp Energia SGPS SA fell at least 2.5 percent as investors sold shares in the companies. Total SA (FP) retreated 1.3 percent following a report that Groupe Bruxelles Lambert SA may dispose of its 4 percent stake in the! French oil producer.

source from Top Stocks For 2015:http://www.topstocksblog.com/top-railroad-companies-to-watch-for-2015.html

Top 5 Small Cap Companies To Own In Right Now

Top 5 Small Cap Companies To Own In Right Now: Achillion Pharmaceuticals Inc.(ACHN)

Achillion Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery, development, and commercialization of treatments for infectious diseases. The company focuses on the development of antivirals for the treatment of chronic hepatitis C; and the development of antibacterials for the treatment of resistant bacterial infections. Its drug candidates for the treatment of chronic HCV include ACH-1625, a protease inhibitor, which is in phase IIa clinical trial for the treatment of chronic HCV; ACH-2684, a pangenotypic protease inhibitor, which is in phase I clinical trial for the treatment of chronic HCV infection; and NS5A inhibitors for the treatment of chronic HCV infection, including ACH-2928, which is to enter a phase I clinical trial, as well as various additional NS5A inhibitors in preclinical development. Its pipeline of product candidates also includes ACH-702 and ACH-2881 for drug resistant bacterial infections; elvucitabine for HIV infection; and AC H-1095 for HCV infection. The company was founded in 1998 and is based in New Haven, Connecticut.

Advisors' Opinion:

• [By John Udovich]

  Since the start of 2014, small cap pharmaceutical stocks Achillion Pharmaceuticals, Inc (NASDAQ: ACHN), Pernix Therapeutics Holdings Inc (NASDAQ: PTX) and Amicus Therapeutics, Inc (NASDAQ: FOLD) are up 286.3%, 262.3% and 248.1%, respectively, making them some of the best performing pharmaceutical stocks for the year. However, a one year share performance, especially for anything in the volatile biotech or pharmaceutical sector, could be just a one time fluke. With that in mind, here is what you need to know or be warned about all three small cap pharmaceutical stocks:

• [By John Udovich]

  Small cap hepatitis stock Achillion Pharmaceuticals, Inc (NASDAQ: A! CHN) saw shares jump on Monday only to then have a minor implosion on Tuesday – meaning its worth taking a look at that hiccup and the history of hiccups or successes from other small cap hepatitis stocks like Idenix Pharmaceuticals Inc (NASDAQ: IDIX), Arrowhead Research Corp (NASDAQ: ARWR) and Alnylam Pharmaceuticals, Inc (NASDAQ: ALNY). It should be mentioned that Hepatitis A, B and C are viral infections that together affect an estimated 5% to 6% of Americans and while globally, 2 billion people (1 out of 3 people) have been infected with hepatitis B with  400 million people chronically infected plus 130–150 million people have chronic hepatitis C - meaning there is plenty of room for large and small cap players alike in the space.

• [By Sean Williams]

  With a gain year-to-date of 328% -- that's three hundred and twenty eight percent -- clinical-stage HCV-focused Achillion Pharmaceuticals (NASDAQ: ACHN  ) absolutely crushed Gilead in total return this year. Amazingly, it did so without having a single product on pharmacy shelves.

• [By Ben Levisohn]

  Having a hard time keeping track of all the competitors for Gilead Sciences’ (GILD) Sovaldi? You’re not the only one, so RBC Capital Market’s Michael Yee and team provide a handy table (click for a larger one) listing the companies with drugs in the works, including AbbVie (ABBV),  Bristol-Myers Squibb (BMY), Achillion Pharmaceuticals (ACHN) and Merck (MRK):

source from Top Stocks For 2015:http://www.topstocksblog.com/top-5-small-cap-companies-to-own-in-right-now-4.html